NYSE:MTNB | Operating Income | Matinas BioPharma Holdings, Inc.

Complete source-backed operating income history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$1.56M
2026-03-31-$1.94M
2025-12-31-$1.6M
2025-09-30-$1.58M
2025-06-30-$1.84M
2025-03-31-$1.95M
2024-12-31-$8.47M
2024-09-30-$4.38M
2024-06-30-$5.84M
2024-03-31-$5.9M
2023-12-31-$5.89M
2023-09-30-$6.13M
2023-06-30-$6.16M
2023-03-31-$5.59M
2022-12-31-$5.48M
2022-09-30-$5.46M
2022-06-30-$5.93M
2022-03-31-$7.72M
2021-12-31-$6.71M
2021-09-30-$6.88M
2021-06-30-$4.79M
2021-03-31-$6.35M
2020-12-31-$6.49M
2020-09-30-$5.6M
2020-06-30-$5.77M
2020-03-31-$6.35M
2019-12-31-$5.74M
2019-09-30-$4.56M
2019-06-30-$4.52M
2019-03-31-$4.1M
2018-12-31-$4.17M
2018-09-30-$2.95M
2018-06-30-$3.4M
2018-03-31-$4.12M
2017-12-31-$4.63M
2017-09-30-$3.41M
2017-06-30-$3.98M
2017-03-31-$4.49M
2016-12-31-$2.56M
2016-09-30-$1.84M
2016-06-30-$1.62M
2016-03-31-$2.24M
2015-12-31-$2.78M
2015-09-30-$2.16M
2015-06-30-$2.4M
2015-03-31-$2.57M
2014-12-31-$3.31M
2014-09-30-$2.61M
2014-06-30-$2.42M
2014-03-31-$2.13M

Annual Operating Income

DateOperating Income
2025-12-31-$6.96M
2024-12-31-$24.59M
2023-12-31-$23.77M
2022-12-31-$24.59M
2021-12-31-$24.74M
2020-12-31-$24.21M
2019-12-31-$18.92M
2018-12-31-$14.65M
2017-12-31-$16.5M
2016-12-31-$8.26M
2015-12-31-$9.91M
2014-12-31-$10.46M
2013-12-31-$3.71M